January 17, 2023
1 min watch
Save
VIDEO: Apellis nears PDUFA date for pegcetacoplan
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
KOLOA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2023, Cedric Francois, MD, PhD, CEO of Apellis, delivers an update on the company’s offerings, including the PDUFA date for the geographic atrophy treatment pegcetacoplan.
“We look forward in the next few years to being a real presence in retina,” he said.
Published by:
Sources/Disclosures
Collapse
Source:
Healio Interviews
Disclosures:
Francois is the CEO of Apellis Pharmaceuticals.
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.